Publication | Closed Access
Binding specificities and affinities of <i>egf</i> domains for ErbB receptors
373
Citations
42
References
1999
Year
Erbb ReceptorsMolecular BiologyCellular PhysiologySignaling PathwayReceptor Tyrosine KinaseFibroblast Growth FactorCell SignalingG Protein-coupled ReceptorReceptor (Biochemistry)PharmacologyCell BiologySignal TransductionFunctional SelectivityNatural SciencesErbb Receptor ActivationCellular BiochemistrySystems BiologyMedicineEleven Erbb LigandsDrug Discovery
ErbB receptor activation is a complex process and is dependent upon the type and number of receptors expressed on a given cell. Previous studies with defined combinations of ErbB receptors expressed in mammalian cells have helped elucidate specific biological responses for many of the recognized gene products that serve as ligands for these receptors. However, no study has examined the binding of these ligands in a defined experimental system. To address this issue, the relative binding affinities of the egf domains of eleven ErbB ligands were measured on six ErbB receptor combinations using a soluble receptor-ligand binding format. The ErbB2/4 heterodimer was shown to bind all ligands tested with moderate to very high affinity. In contrast, ErbB3 showed much more restrictive ligand binding specificity and measurable binding was observed only with heregulin, neuregulin2beta, epiregulin and the synthetic heregulin/egf chimera, biregulin. These studies also revealed that ErbB2 preferentially enhances ligand binding to ErbB3 or ErbB4 and to a lesser degree to ErbB1.
| Year | Citations | |
|---|---|---|
Page 1
Page 1